stockrowCareDx, Inc. (CDNA) vs GRAIL, Inc. (GRAL)
- CareDx, Inc. CDNA 78.30 +2.58%
- GRAIL, Inc. GRAL 125.01 +4.94%
CareDx, Inc. and GRAIL, Inc. are both Diagnostics & Research companies. GRAIL, Inc. is the larger, with a market value of $5.3B against $4.0B — 1.3× the size. GRAIL, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 17.5%. CareDx, Inc. has the higher net margin (25.9% vs −243.8%) and the higher return on invested capital (33.6% vs −14.7%). Across the 16 metrics below, CareDx, Inc. leads on 12 and GRAIL, Inc. on 4.
Valuation
Profitability
| Metric | CDNA | GRAL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.97% | 0.00% | 48.32% |
| Operating margin | 23.42% | (347.28%) | (5.68%) |
| Net margin | 25.86% | (243.80%) | (4.10%) |
| Free cash flow margin | 12.01% | (187.27%) | 0.00% |
| Return on equity | 33.04% | (17.31%) | 0.00% |
| Return on assets | 23.96% | (15.24%) | (6.05%) |
| Return on invested capital | 33.56% | (14.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack